SCIOS INC
Scios Inc. is a pharmaceutical company developing drugs for the treatment of cardiovascular and inflammatory diseases. The company is a subsidiary of Johnson & Johnson. The company’s portfolio of drugs includes NatrecorO, a promising drug for heart failure. Scios Inc. was founded in 1981 and is based in California.
SCIOS INC
Industry:
Biotechnology Health Care Medical
Founded:
1981-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Status:
Active
Contact:
(408)616-8200
Similar Organizations
AntiRadical Therapeutics
AntiRadical Therapeutics focuses on developing drugs for the treatment of blood flow disruption.
CE3 Inc.
CE3 is a pharmaceutical company providing gene therapy and cardio-vascular indication solutions.
Gordagen Pharmaceuticals
Gordagen Pharmaceuticals is a private Australian company, developing novel treatments for hyperlipidaemia, diabetes, inflammatory diseases
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer.
Current Employees Featured
Founder
More informations about "Scios Inc"
Lessons Learned From The Rise And Fall Of Scios
Apr 7, 2017 The company, kept afloat by venture funding and contract research, eventually became Scios Inc. But turning nesiritide into a multi-million dollar dream therapy would mean big-money, big-risk clinical research. ... it would …See details»
Scios, Inc. - Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Explore Scios, Inc. with its drug pipeline, therapeutic area, technology platform, 37 clinical trials, 8 news, and 154 literature, Disease Domain:Nervous System Diseases, Infectious Diseases, …See details»
Scios Company Profile | Management and Employees List - Datanyze
Scios Inc. is developing novel treatments for cardiovascular disease, inflammatory disease and cancer. The company's disease-based technology platform integrates expertise in protein …See details»
Working At Scios Inc: Company Overview and Culture - Zippia
May 18, 2020 51% of Scios Inc employees are women, while 49% are men. The most common ethnicity at Scios Inc is White (51%). 21% of Scios Inc employees are Hispanic or Latino. 13% …See details»
Scios Inc - Company Profile and News - Bloomberg Markets
Scios Inc., operates as a biopharmaceutical company. The Company discovers, develops, manufactures, and commercializes novel human therapeutics. Scios is developing a product …See details»
Scios (Drug Discovery) - PitchBook
Feb 27, 2008 Scios (Drug Discovery) General Information Description. Operator of a biopharmaceutical company. The company engages in the discovery, development, …See details»
Scios, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jun 13, 2023 Explore Scios, Inc. with its drug pipeline, therapeutic area, technology platform, 37 clinical trials, 3 news, and 112 literature.See details»
Scios' long, long road / Biotech firm's success took …
Sep 24, 2001 Andy Protter,Senior Director, Scios Inc., holds a DNA sequencing gel. In the early days of Scios Protter would have to manually extract DNA from the clones then manually read each band of code to ...See details»
BioPharmaLink profile of Scios Inc., United States of America,
Scios Inc.: Scios Inc. is a biopharmaceutical company whose goal is to discover, develop and commercialize novel human therapeutics for the treatment of cardiorenal and inflammatory …See details»
Scios Inc | www.inknowvation.com
Previously known as California Biotechnology Inc, the firm was first renamed Scios Nova Inc and then Scios. The firm was an early established biopharmaceutical company engaged in the …See details»
Scios Inc - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Scios Inc . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. About. Scios Inc has 4 current …See details»
J&J Buys Scios to Boost Biotech Position - ourmidland.com
Feb 9, 2003 Johnson & Johnson, the health-care giant the public knows for its baby, skin and wound-care products, is boosting its biotech might with the acquisition of Scios Inc. in a $2.4 …See details»
Scios Inc - Crunchbase
Organization. Scios Inc . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. ... Scios Inc and Apogenix share similar …See details»
Scios Inc - Pharmaceuticals - Overview, Competitors, and Employees
View Scios Inc revenue, competitors and contact information. Find and reach Scios Inc's employees by department, seniority, title, and much more.See details»
Scios Inc. Announces International Outcomes Trial Of ... - BioSpace
Jun 1, 2006 In the coming months, Scios will finalize and announce the independent academic research organization that will oversee and execute the trial, including a study chair, principal …See details»
Late-Bloomer Scios Inc. Leads Stocks / THE CHRONICLE 500
May 7, 2001 Scios Chief Executive Officer Richard Brewer, who took over in 1998, said the company's... Late-Bloomer Scios Inc. Leads Stocks / THE CHRONICLE 500 SF Gate Logo …See details»
SCIOS INC | TREA
Jul 20, 2024 Stents and intra-luminal prostheses containing map kinase inhibitors. Patent number 7,244,441; Issue date Jul 17, 2007; Scios, Inc. George F. SchreinerSee details»
United States Joins Suits Against Scios and Johnson & Johnson
Feb 19, 2009 The United States has intervened in two whistleblower suits filed in the Northern District of California against the drug manufacturer Scios Inc. and its parent company, …See details»
SCIOS INC Top 13F Holdings - WhaleWisdom.com
Scios is based out of Sunnyvale. Scios Inc.'s principal activity is to develop novel drugs for the treatment of cardiovascular and inflammatory diseases. The Group's disease-based …See details»